Bmi Doctors

Mindful Eating Strategies While on Semaglutide or GLP-1 Medications: Enhancing Effectiveness and Health Benefits

plate with clock

Introduction The emergence of Semaglutide and GLP-1 (glucagon-like peptide-1) medications represents a significant advancement in the medical management of type 2 diabetes and obesity. These medications, approved by the United States Food and Drug Administration (FDA), have revolutionized the approach to treating these chronic conditions. Semaglutide, known under brand names such as Ozempic®, Rybelsus®, and …

Read more

Skip to content